Scott Nolan
Co-Founder and CEO @ General Matter
San Francisco, United States
Scott Nolan is a seed investor at General Matter in San Francisco focused on Software and Medical. Partner at Founders Fund.
- Total investments:
- 38
- Last investment:
- Lead investor:
- 37%
Last updated:
For AI agents: llms.txt
Industries Scott Nolan invests in
SoftwareMedicalHealth CareEnergyNuclear
Stages Scott Nolan invests in
SeedSeries ASeries BSeries DSeries C
Countries Scott Nolan invests in
United StatesNew ZealandBrazil
Round sizes
Seed $620k–$17MSeries A $4M–$45MSeries B $32M–$150M
Round size
- Seed
- $620k–$17M
- Series A
- $4M–$45M
- Series B
- $32M–$150M
Investment Focus
Industry
- Software 5 (13%)
- Medical 3 (8%)
- Health Care 3 (8%)
- Energy 2 (5%)
- Nuclear 2 (5%)
Stage
- Seed 10 (26%)
- Series A 6 (16%)
- Series B 6 (16%)
- Series D 3 (8%)
- Series C 2 (5%)
Country
- United States 16 (42%)
- New Zealand 2 (5%)
- Brazil 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Impulse Space
|
Impulse Space develops spacecraft and propulsion systems that provide transportation and mobility services for payloads operating in space. The company focuses on moving, deploying, and hosting payloads across a range of orbital destinations, including low Earth orbit, geostationary orbit, and other deep-space trajectories. Its vehicle portfolioincludes Mira, a spacecraft designed for payload hosting, deployment, and orbital maneuvers, and Helios, a transfer vehicle intended to transport larger payloads between orbits. Impulse Space designs, manufactures, and tests much of its hardware in-house, covering spacecraft systems, propulsion components, and mission integration. The company supports commercial, civil, and government missions by providing in-space transportation and logistics capabilities after launch. | $500M / Series D / Jun 02, 2026 | |
Freeform
|
Freeform is a 3D printing company offering metal 3D printing solutions for manufacturing companies. Freeform deploys software-defined, self-sufficient metal 3D printing factories around the world, bringing software scalability to physical production. Freeform's technology stack combines advanced sensing, real-time controls, and data-drivenlearning to produce digitally-verified, flawless parts at previously unheard-of speeds and costs. | $67M / Series B / Jan 07, 2026 | |
Radiant
|
Radiant is a technology company that develops portable nuclear microreactors designed to generate electricity and heat in a compact, factory-built form. The company’s flagship product, Kaleidos, is engineered to be transportable to customer sites and to replace traditional power sources such as diesel generators for applications including backuppower and continuous energy supply. Radiant manages design, assembly, fueling, and testing of its reactors with a focus on modular deployment and energy generation without on-site water requirements. It also undertakes infrastructure planning for reactor production facilities to support broader availability of its microreactors. Radiant engages with regulatory processes and industry partners to advance testing and commercialization of its nuclear energy solutions. | $300M / Series D / Dec 17, 2025 | |
Network Bio
|
Network Bio is a clinical and molecular data library enabling precision medicine approaches for common human diseases. Its platform delivers a centralized repository for clinical and molecular data that allows researchers to identify patterns and correlations that can be used to develop new treatments and diagnostic tools. | $17M / Seed / Feb 27, 2025 | |
|
Radiant
|
Radiant is a technology company that develops portable nuclear microreactors designed to generate electricity and heat in a compact, factory-built form. The company’s flagship product, Kaleidos, is engineered to be transportable to customer sites and to replace traditional power sources such as diesel generators for applications including backuppower and continuous energy supply. Radiant manages design, assembly, fueling, and testing of its reactors with a focus on modular deployment and energy generation without on-site water requirements. It also undertakes infrastructure planning for reactor production facilities to support broader availability of its microreactors. Radiant engages with regulatory processes and industry partners to advance testing and commercialization of its nuclear energy solutions. | $165M / Series C / Nov 14, 2024 | |
|
Impulse Space
|
Impulse Space develops spacecraft and propulsion systems that provide transportation and mobility services for payloads operating in space. The company focuses on moving, deploying, and hosting payloads across a range of orbital destinations, including low Earth orbit, geostationary orbit, and other deep-space trajectories. Its vehicle portfolioincludes Mira, a spacecraft designed for payload hosting, deployment, and orbital maneuvers, and Helios, a transfer vehicle intended to transport larger payloads between orbits. Impulse Space designs, manufactures, and tests much of its hardware in-house, covering spacecraft systems, propulsion components, and mission integration. The company supports commercial, civil, and government missions by providing in-space transportation and logistics capabilities after launch. | $150M / Series B / Oct 01, 2024 | |
9amHealth
|
9amHealth is a virtual healthcare company focused on managing chronic cardiometabolic conditions such as diabetes, obesity, high blood pressure, and high cholesterol. The platform connects patients with licensed healthcare providers, pharmacists, nutritionists, prescription delivery services, and at-home laboratory testing through a digital caremodel. Its services include personalized treatment plans, medication management, ongoing monitoring, and remote consultations designed to support long-term condition management. The company also works with employers, health plans, and pharmacy benefit managers to provide healthcare support programs for individuals living with chronic illnesses. 9am.health’s care approach combines medical treatment, behavioral support, and digital tools to help patients access healthcare services remotely and manage their conditions more consistently. | $9.5M / Series A / Feb 19, 2024 | |
|
Impulse Space
|
Impulse Space develops spacecraft and propulsion systems that provide transportation and mobility services for payloads operating in space. The company focuses on moving, deploying, and hosting payloads across a range of orbital destinations, including low Earth orbit, geostationary orbit, and other deep-space trajectories. Its vehicle portfolioincludes Mira, a spacecraft designed for payload hosting, deployment, and orbital maneuvers, and Helios, a transfer vehicle intended to transport larger payloads between orbits. Impulse Space designs, manufactures, and tests much of its hardware in-house, covering spacecraft systems, propulsion components, and mission integration. The company supports commercial, civil, and government missions by providing in-space transportation and logistics capabilities after launch. | $45M / Series A / Jul 24, 2023 | |
Siren Biotechnology
|
Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.AAV gene therapy and cytokine immunotherapy are two revolutionary treatment approaches that Siren Biotechnology has combined into a single, redesigned modality. This approach overcomes significant obstacles and entirely transformshow tumor cells are eliminated and anti-tumor immunity is stimulated. | Seed / May 17, 2023 | |
|
Radiant
|
Radiant is a technology company that develops portable nuclear microreactors designed to generate electricity and heat in a compact, factory-built form. The company’s flagship product, Kaleidos, is engineered to be transportable to customer sites and to replace traditional power sources such as diesel generators for applications including backuppower and continuous energy supply. Radiant manages design, assembly, fueling, and testing of its reactors with a focus on modular deployment and energy generation without on-site water requirements. It also undertakes infrastructure planning for reactor production facilities to support broader availability of its microreactors. Radiant engages with regulatory processes and industry partners to advance testing and commercialization of its nuclear energy solutions. | $40M / Series B / Apr 18, 2023 | |
| See all 38 investments → | |||
Co-Investors
About General Matter
General Matter is a nuclear energy company that restores nuclear power and produce enriched uranium.
General Matter Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Scott Nolan
Co-Founder and CEO
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
SaaS Investors
99,274 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Energy Investors
25,111 investors
Medical Investors
18,848 investors
SaaS VC Funds
61,208 investors
Software VC Funds
31,919 investors
Health Care VC Funds
32,370 investors
Energy VC Funds
20,690 investors
FAQ
What does Scott Nolan invest in?
Scott Nolan invests primarily in Software, Medical and Health Care startups, most often at Seed and Series A stage. Most of the 38 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Scott Nolan's check size?
Scott Nolan typically joins rounds of $620k–$17M at Seed, $4M–$45M at Series A and $32M–$150M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Scott Nolan participates in.
When did Scott Nolan last invest?
The most recent investment recorded for Scott Nolan closed in Jun 2026. Shizune tracks 38 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
